Quadrant Capital Group LLC Deciphera Pharmaceuticals, Inc. Transaction History

Quadrant Capital Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$10.11 - $16.54 $404 - $661	40 Added 2.08%	1,965 $31,000
Q4 2022 Feb 10, 2023	SELL	$14.85 - $19.04 $3,118 - $3,998	-210 Reduced 9.84%	1,925 $31,000
Q3 2022 Nov 10, 2022	BUY	$12.38 - $20.23 $1,968 - $3,216	159 Added 8.05%	2,135 $39,000
Q2 2022 Aug 09, 2022	BUY	$9.11 - $13.98 $355 - $545	39 Added 2.01%	1,976 $26,000
Q1 2022 May 06, 2022	SELL	$6.87 - $11.11 $13,156 - $21,275	-1,915 Reduced 49.71%	1,937 $18,000
Q4 2021 Feb 01, 2022	BUY	$7.7 - $37.13 $29,437 - $141,947	3,823 Added 13182.76%	3,852 $38,000
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $767 - $1,077	29 New	29 $1,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.